“Immunological and Clinical Aspects Determining the Risk of Recurrence in Patients with Luminal Subtype of Breast Cancer Stages I–III” (2025) Voprosy onkologii, 71(3), p. OF-2271. doi:10.37469/0507-3758-2025-71-3-OF-2271.